ArticleAmerican journal of respiratory and critical care medicine2016

Promise and Limitations of Relaxin-based Therapies in Chronic Fibrotic Lung Diseases.

Simon G Royce et al.PubMed ↗Publisher ↗

No numbers read from the abstract.